Paediatric addendum to the guideline on clinical investigation on medicinal products in the treatment of hypertension
| Current effective version |
|
| Reference number | EMA/CHMP/206815/2013 |
| Published | 26/03/2015 |
| Effective from | 01/09/2015 |
| Keywords | Paediatric, drug evaluation, drug approval guideline, hypertension, clinical evaluation, efficacy criteria, safety aspects |
| Description | This document is an addendum to the guideline on clinical investigation of medicinal products in the treatment of hypertension. It highlights differences from adult patients with arterial hypertension and points out paediatric-specific aspects. |
Document history
First version Current version | In operation: 01/09/2015–present Published: 26/03/2015 Published: 30/09/2013 Published: 18/12/2008 |
Related content
- Clinical investigation on medicinal products in the treatment of hypertension
- Clinical trials in small populations
- ICH E11 Clinical investigation of medicinal products in the paediatric population
- Impact of renal immaturity when investigating medicinal products intended for paediatric use
- Pharmaceutical development of medicines for paediatric use
- Role of pharmacokinetics in the development of medicinal products in the paediatric population